Cell Therapeutics, Inc. (NASDAQ:CTIC) climbed up 1.91% to $0.788 on a massive volume of 9.56 million shares. The stock has a 52-week range of $0.05-$2.23. Cell Therapeutics, Inc. (Cell Therapeutics) develops, acquires and commercializes treatments for cancer. The Company’s research, development, acquisition and in-licensing activities concentrate on identifying and developing new, less toxic and effective ways to treat cancer.
Subscribe to daily free stock newsletter by visiting: http://www.pennystockpickreport.com/.
Athersys, Inc. (NASDAQ:ATHX) is amongst the top gainer in the early few hours. The stock has spurted 27.78% and is trading at $3.68 with a massive volume of 5.71 million shares. The stock has a 52-week range of $0.45-$6.40. Reuters reported that Athersys has been granted two U.S. patents that cover its proprietary MultiStem technology, an investigational stem cell therapy. The Company said the issued patents cover its technology which is used to treat diseases and indications, including heart attack, inflammatory bowel disease.
StemCells, Inc. (NASDAQ:STEM) rallied 3.42% to $1.21 on a massive volume of 1.98 million shares. The stock has a 52-week range of $1.02-$2.54. The company announced today that its proprietary HuCNS-SC® human neural stem cells have been used to treat the first patient enrolled in its Phase I clinical trial in Pelizaeus-Merzbacher Disease (PMD), a myelination disorder that afflicts male children. The stem cells were administered yesterday at the University of California, San Francisco (UCSF) Children's Hospital by direct injection into the brain of a patient with connatal PMD, the most severe form of the disease. This marks the first time that neural stem cells have been transplanted as a potential treatment for a myelination disorder, and the second clinical trial involving the use of HuCNS-SC cells in a neurodegenerative disease.
About http://www.pennystockpickreport.com/
Penny Stock Pick Report offers a stock newsletter on OTC, PINKSHEETS ,OTCBB, and AMEX Stocks. Our subscribers receive daily up to date stock information on midcap, smallcap penny stocks and also stocks that are traded at NASDAQ and NYSE stock exchange. If you wish to feature your organization on our website then you can contact us at the email given below.
